Patents by Inventor Jeffrey B Locke

Jeffrey B Locke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SINGLE DOSE METHODS FOR PREVENTING AND TREATING FUNGAL INFECTIONS
    Publication number: 20230181689
    Abstract: Provided herein are methods for treating, mitigating, or preventing fungal infections or related conditions thereto in a human subject in need thereof. The methods include the administration of a single dose of a pharmaceutical composition comprising or consisting of CD101 and any pharmaceutically acceptable excipients, wherein the single dose treatment substantially reduces or eliminates the fungal infection.
    Type: Application
    Filed: August 4, 2022
    Publication date: June 15, 2023
    Inventors: Kenneth BARTIZAL, Paul DARUWALA, Jeffrey B. LOCKE, Voon ONG, Taylor SANDISON
  • SINGLE DOSE METHODS FOR PREVENTING AND TREATING FUNGAL INFECTIONS
    Publication number: 20190307843
    Abstract: Provided herein are methods for treating, mitigating, or preventing fungal infections or related conditions thereto in a human subject in need thereof. The methods include the administration of a single dose of a pharmaceutical composition comprising or consisting of CD101 and any pharmaceutically acceptable excipients, wherein the single dose treatment substantially reduces or eliminates the fungal infection.
    Type: Application
    Filed: October 30, 2017
    Publication date: October 10, 2019
    Inventors: Kenneth BARTIZAL, Paul DARUWALA, Jeffrey B. LOCKE, Voon ONG, Taylor SANDISON
  • THERAPEUTIC COMBINATION OF DAPTOMYCIN AND PROTEIN SYNTHESIS INHIBITOR ANTIBIOTIC, AND METHODS OF USE
    Publication number: 20130274174
    Abstract: A therapeutic combination comprises an antibacterially effective amount of daptomycin, and an amount of protein synthesis inhibitor antibiotic effective to prevent the development of daptomycin non-susceptibility in bacteria. Related combination therapies and methods are also included.
    Type: Application
    Filed: June 6, 2013
    Publication date: October 17, 2013
    Inventors: Kenneth F. Bartizal, Jeffrey B. Locke, Karen Joy Shaw, Philippe G. Prokocimer
  • Therapeutic combination of daptomycin and protein synthesis inhibitor antibiotic, and methods of use
    Patent number: 8461188
    Abstract: A therapeutic combination comprises an antibacterially effective amount of daptomycin, and an amount of protein synthesis inhibitor antibiotic effective to prevent the development of daptomycin non-susceptibility in bacteria. Related combination therapies and methods are also included.
    Type: Grant
    Filed: October 19, 2012
    Date of Patent: June 11, 2013
    Assignee: Trius Therapeutics, Inc.
    Inventors: Kenneth F Bartizal, Jeffrey B Locke, Karen Joy Shaw, Philippe G Prokocimer